DesRosier Thomas — SEC insider filings
SEC reporting owner CIK 1435744. 21 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2021-02-08 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 14 filings — 19,821 shares, $23,216 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 52.
- Largest priced transaction: sale of 4,156 shares @ $1.35 ($5,611) in Seres Therapeutics, Inc., filed 2023-10-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | See Remarks | 21 | — | 14 legs · 19,821 sh · $23,216 | 52 |
Insider filings — DesRosier Thomas
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 244 · Sale (S): 103 @ $1.38 · Option exercise (M): 133 (derivative) @ $0 · Option exercise (M): 111 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 245 · Sale (S): 82 @ $4.55 · Option exercise (M): 133 (derivative) @ $0 · Option exercise (M): 112 (derivative) @ $0 | EDGAR |
| 2026-07-10 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 244 · Sale (S): 79 @ $7.53 · Option exercise (M): 133 (derivative) @ $0 · Option exercise (M): 111 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 244 · Sale (S): 78 @ $8.47 · Option exercise (M): 133 (derivative) @ $0 · Option exercise (M): 111 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 132 · Option exercise (M): 112 · Sale (S): 76 @ $17.30 · Option exercise (M): 132 (derivative) @ $0 · Option exercise (M): 112 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 133 · Option exercise (M): 111 · Sale (S): 76 @ $16.65 · Option exercise (M): 133 (derivative) @ $0 · Option exercise (M): 111 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 133 · Option exercise (M): 111 · Sale (S): 79 @ $7.28 · Option exercise (M): 133 (derivative) @ $0 · Option exercise (M): 111 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 2,657 · Option exercise (M): 8,907 · Sale (S): 4,300 @ $0.81 · Option exercise (M): 2,657 (derivative) @ $0 · Option exercise (M): 8,907 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 650,000 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 2,656 · Sale (S): 878 @ $0.54 · Option exercise (M): 2,656 (derivative) @ $0 | EDGAR |
| 2024-10-29 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 13,500 @ $0 · Sale (S): 4,259 @ $0.69 · Option exercise (M): 13,500 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 2,656 · Sale (S): 873 @ $0.84 · Option exercise (M): 2,656 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 2,656 · Sale (S): 843 @ $0.94 · Option exercise (M): 2,656 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 10,625 · Sale (S): 3,939 @ $1.08 · Grant/award (A): 213,750 (derivative) @ $0 · Grant/award (A): 287,905 (derivative) @ $0 · Grant/award (A): 35,625 (derivative) @ $0 · Option exercise (M): 10,625 (derivative) @ $0 | EDGAR |
| 2023-10-31 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 13,501 @ $0 · Sale (S): 4,156 @ $1.35 · Grant/award (A): 27,001 (derivative) @ $0 · Option exercise (M): 13,501 (derivative) @ $0 | EDGAR |
| 2023-02-07 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 42,500 (derivative) @ $0 · Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2022-07-06 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 63,492 @ $3.15 | EDGAR |
| 2022-02-08 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2021-02-08 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1435744 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs